A new shareholder into our business

Biomaneo is collecting additional financial resources from BFC Croissance & Innovation to continue the development of screening for the most widespread genetically transmissible disease in the world: sickle cell disease.

The development of Biomaneo continues. As a sign of the confidence it is inspiring, the Dijon-based company, supported by the incubator of the Microtechniques Cluster, has just completed the second fundraising in its history, with the entry into the capital of BFC Croissance & Innovation (Banque Populaire Bourgogne-Franche-Comté).

> Website : https://www.tracesecritesnews.fr/actualite/le-coin-de-start-up-biomaneo-avec-ses-kits-de-depistage-medical-et-cirkwi-avec-son-moteur-de-recherche-touristique-157478

Press review